Skip to content

A safety study of HAL therapy for gait disturbance due to acute stroke

A safety study of HAL therapy for gait disturbance due to acute stroke - Safety of HAL therapy for acute stroke

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024775
Enrollment
16
Registered
2016-11-09
Start date
2016-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute stroke (Cerebral infarction, Cerebral hemorrhage)

Interventions

Gait training utilizing HAL(hybrid assistive limb, HAL-ML05) for 40 minutes and conventional physical therapy for 20 minutes per day, 5 times a week, combined with conventional physical therapy for 60

Sponsors

Ichinomiya Nishi Hospital Department of Neurology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Age:20-89 years old 2)Confirmation of acute ischemic or hemorrhagic stroke lesion on MRI/CT, associated with hemiplegia 3)Time since stroke onset within 7-14 days. 4)Functional Ambulation Category (FAC) score of 0-2 5)Patient can ensure more than 4 weeks from intervention initiation. 6) Patient can consent by a document.

Exclusion criteria

Exclusion criteria: 1)Patient who cannot be suitable for HAL. 2)Patient who cannot walk with HAL. 3)Disturbance of consciousness 4)MMSE score is less than 23. 5)Pre-stroke mRS score is above 2. 6)Severe cardio-pulmonary dysfunction( NYHA; stage III or IV) 7)Patient treated with intravenous drip or oxygen inhalation.

Design outcomes

Primary

MeasureTime frame
Adverse event(accident during HAL therapy,stroke recurrence,complication of severe systemic disease)

Secondary

MeasureTime frame
Body Impairment Outcome Measures Brunnstrom stage (BRs) 12grade hemiplesia functional test Fugl-meyer assessment 6m-Gait speed,Stride,Cadence,Gait distance for 6 min NIHSS Activity/Disability Outcome Measures modified Rankin Scale (mRS) Barthel Index (BI) Functional Independence Measure (FIM) Others MMSE Medical Outcomes Study Short Form 36(SF36)

Countries

Japan

Contacts

Public ContactKeiji Yamaguchi

Ichinomiya Nishi Hospital Department of Neurology

k-yamaguchi@anzu.or.jp+81-586-48-0077

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026